Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases

Conditions

• Benign or Malignant Pancreatic Diseases

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Study Details

This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, Texas(TX). The investigators plan to conduct an analysis of patients meeting the inclusion criteria from 2005 to present. Study will also be conducted by the PI, Sub-Is, surgery fellows, office staff and clinical research coordinator who are delegated to do by the PI. Data will be obtained by looking through either investigator's patients or through a national database. Data will be analyzed primarily by the study conductors.

Key Dates

Start date

Mar 5, 2019

Status verified

Jan 2026

Primary completion

Jan 30, 2027

Completion

Jan 30, 2028

Study Design

Enrollment

500 participants (estimated)

Primary Outcome Measure

Overall survival [ Time Frame: 2005 to 2019 ]

Central Contacts

• Crystee Cooper, DHEd
  214-947-1280
  [email protected]
• Nitasha Phatak, Ph.D.
  214-947-4459
  [email protected]

Locations (1)

Find similar trials in Richardson, TX